{"id":2023,"date":"2026-10-16T04:55:23","date_gmt":"2026-10-16T04:55:23","guid":{"rendered":"https:\/\/achaiki-iatriki.gr\/?p=2023"},"modified":"2026-10-16T07:18:27","modified_gmt":"2026-10-16T07:18:27","slug":"patient-reported-outcomes-2-14-11-36-56-7","status":"publish","type":"post","link":"https:\/\/achaiki-iatriki.gr\/?p=2023","title":{"rendered":"Extracolonic manifestations of Clostridioides difficile infection: Thinking Beyond the Gut"},"content":{"rendered":"

ACHAIKI IATRIKI | 2026; 45(3):131\u2013134<\/span><\/p>\n

Editorial<\/em><\/span><\/p>\n

Konstantinos C. Mpakogiannis1<\/sup>, Ioanna-Nefeli Mastorogianni1<\/sup>, Fotios S. Fousekis2<\/sup>, Konstantinos H. Katsanos1<\/sup><\/p>\n

<\/p>\n

\n

1<\/sup>Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece
\n2<\/sup>Medical Department 2, Academic Teaching Hospital F\u00fcrth, Friedrich-Alexander Universit\u00e4t Erlangen-N\u00fcrnberg, F\u00fcrth, Germany<\/p>\n

Received: 14 Jun 2026; Accepted: 15 Jul 2026<\/span><\/p>\n

Corresponding author:<\/strong> Konstantinos H. Katsanos, Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece, E-mail: khkostas@hotmail.com<\/a><\/p>\n

\"\"<\/a><\/p>\n

 <\/p>\n

\n
INTRODUCTION<\/strong><\/h5>\n

Clostridioides difficile<\/em> (C. difficile<\/em>) is a Gram-positive, spore-forming anaerobic bacterium that is widely recognized as the leading cause of antibiotic-associated diarrhea and pseudomembranous colitis [1]. Although C. difficile <\/em>primarily affects the colon, cases of extraintestinal manifestations are increasingly reported in the medical literature [2]. These manifestations include both infectious and non-infectious complications and account for less than 1% of all reported C. difficile <\/em>infections [3].<\/p>\n

Risk factors and pathogenesis<\/strong><\/p>\n

Prior exposure to broad-spectrum antibiotics remains the most important predisposing factor, as disruption of the normal intestinal microbiota facilitates colonization and overgrowth of C. difficile<\/em> [4].<\/p>\n

Advanced age, prolonged hospitalization, proton pump inhibitor use, immunosuppression, malignancy, diabetes mellitus, chronic liver and kidney disease, cardiovascular disease, and sickle cell disease are other significant risk factors [5].<\/p>\n

The development of extraintestinal manifestations is thought to result primarily from disruption of the intestinal mucosal barrier, as occurs in severe colitis, inflammatory bowel disease, intestinal surgery, bowel perforation, and gastrointestinal malignancies, which facilitates the translocation of C. difficile <\/em>and other microorganisms of the normal intestinal microbiota into the bloodstream, enabling their subsequent dissemination to distant organs [6]. In some cases, however, extraintestinal manifestations occur in the absence of gastrointestinal disease, suggesting that additional mechanisms may be involved [2,7]. These mechanisms may include hematogenous spread from asymptomatic intestinal colonization, toxin-mediated effects, or direct inoculation of the bacterium into tissues during trauma, surgery, or invasive medical procedures [2,6].<\/p>\n

Bacteremia and sepsis-like syndrome<\/strong><\/p>\n

Bacteremia is the most frequently reported extraintestinal manifestation of C. difficile <\/em>infection [2]. Underlying malignancy and chronic liver disease are frequently identified in affected patients [8]. Although monomicrobial bacteremia can occur, it is considerably less common than polymicrobial bacteremia and may reflect the presence of an extraintestinal infectious focus [5,6]. The development of sepsis-like syndrome may be attributed to toxin A\u2013induced neutrophil chemotaxis and intestinal barrier dysfunction, which allows toxins and microbes to enter the bloodstream.<\/p>\n

Abdominal and pelvic infections and abscesses<\/strong><\/p>\n

Abdominal and pelvic infections represent the most common extraintestinal C. difficile <\/em>infections [2]. These infections occur predominantly in patients with underlying immunosuppression or conditions that compromise the intestinal barrier [2]. Splenic abscesses may arise through hematogenous dissemination, trauma, or splenic infarction [2]. Clinical manifestations are often nonspecific and include fever, abdominal pain, weight loss, leukocytosis, and elevated inflammatory markers [2]. Liver and pancreatic abscesses are rare [2]. Many intra-abdominal infections are polymicrobial, with Escherichia coli<\/em> and Enterococcus<\/em> species frequently isolated alongside C. difficile<\/em> [2,9]. Hypervirulent ribotype 027 strains have also been implicated in several cases [7].<\/p>\n

Central nervous system infections and abscesses<\/strong><\/p>\n

Only a few cases of brain abscesses caused by C. difficile <\/em>have been reported [10,11]. In one case, the infection developed secondary to suppurative otitis media, while another case occurred in a patient with a history of subdural hematoma and asymptomatic intestinal carriage of C. difficile <\/em>[10,11]. Interestingly, some reported CNS infections involve non-toxigenic strains, suggesting that strains with lower intestinal virulence may persist in the gut and cause opportunistic infections [11]. Patients with central nervous system infections and abscesses may present without gastrointestinal symptoms, making diagnosis particularly challenging [2].<\/p>\n

Pleuropulmonary infections<\/strong><\/p>\n

Pleuropulmonary infections associated with C. difficile <\/em>include pleural effusions, empyema, and, in severe cases, necrotizing pneumonia [2]. Most reported cases have occurred following thoracic surgery, thoracentesis, chest trauma, or other invasive procedures, suggesting direct inoculation into the respiratory tract as the primary mechanism [12,13]. Patients may present with fever, chest pain, and dyspnea [2].<\/p>\n

Bone and joint infections<\/strong><\/p>\n

Bone and joint infections are frequently reported extraintestinal manifestations [2]. Septic arthritis may affect both native and prosthetic joints, although prosthetic joint infections are considerably more common [2]. Native joint infections have been particularly documented in patients with sickle cell disease, where intestinal ischemia and immune dysfunction may facilitate bacterial translocation into the bloodstream [2,14].<\/p>\n

Prosthetic joint infections are believed to result mainly from direct contamination during surgery [2]. These infections are usually monomicrobial, supporting the hypothesis of direct inoculation rather than hematogenous spread [2]. Clinical manifestations include joint pain, swelling, fever, and elevated inflammatory markers [2].<\/p>\n

Osteomyelitis caused by C. difficile <\/em>is rare but tends to become chronic [15]. Cases usually involve long bones, often following trauma, surgery, or previous hospitalization [2].<\/p>\n

Soft tissue and surgical site infections<\/strong><\/p>\n

Soft tissue infections caused by C. difficile <\/em>include cases of cellulitis, wound infections, abscesses, and necrotizing fasciitis [2]. Trauma and surgical interventions are major predisposing factors, with direct wound contamination from environmental or nosocomial sources of C. difficile <\/em>representing the most likely pathogenic mechanism [2].<\/p>\n

Published case reports have identified toxigenic strains in infected wounds, whereas different strains were isolated from the patients\u2019 gastrointestinal tracts [16,17]. This observation suggests that infection may originate from environmental contamination [2]. Nevertheless, intestinal colonization may also contribute to infection during abdominal surgical procedures [2].<\/p>\n

Clinical presentations range from localized wound infections to rapidly progressive necrotizing soft tissue infections [2].<\/p>\n

Cardiovascular infections<\/strong><\/p>\n

Cardiovascular manifestations are rare but potentially life-threatening [2]. Reported cases include mycotic aneurysms, infected vascular grafts and endovascular prostheses, intracardiac vegetations, pericarditis, epicardial patch infections, and pacemaker-associated infections [2].<\/p>\n

The most widely accepted pathogenic mechanism involves hematogenous dissemination following bacterial translocation across the gastrointestinal mucosal barrier [2]. Many affected patients have concurrent intestinal disease and positive stool toxin tests [2]. Previous vascular interventions may further increase susceptibility to infection by creating localized anaerobic conditions that favor bacterial proliferation [18].<\/p>\n

Reactive arthritis and other non-infectious manifestations<\/strong><\/p>\n

The most common non-infectious extraintestinal manifestation of C. difficile <\/em>infection is reactive arthritis [2].<\/p>\n

Reactive arthritis typically develops within days to weeks after the onset of diarrhea and commonly affects the knees, ankles, and wrists [6].<\/p>\n

Underlying pathogenesis is believed to result from increased intestinal permeability, which facilitates systemic exposure to bacterial antigens and triggers an aberrant immune response [6]. More than half of affected patients are positive for the HLA-B27 antigen, although its precise role remains uncertain [19].<\/p>\n

Other rare non-infectious manifestations include Takotsubo syndrome, leukocytoclastic vasculitis, and syndrome of inappropriate antidiuretic hormone secretion (SIADH), underscoring the potential systemic effects of C. difficile <\/em>toxins and associated immune dysregulation [2,20].<\/p>\n

CONCLUSION<\/strong><\/h5>\n

Although C. difficile <\/em>is primarily recognized as an intestinal pathogen responsible for pseudomembranous colitis, it may occasionally cause a wide spectrum of extraintestinal manifestations. Increased awareness of these rare manifestations is essential for timely diagnosis and appropriate management, and further research is needed to elucidate their pathogenesis, identify prognostic markers, and optimize therapeutic strategies.<\/p>\n

Conflict of interest<\/strong><\/h5>\n

None to declare.<\/p>\n

Declaration of funding sources<\/strong><\/h5>\n

None to declare.<\/p>\n

Author contributions<\/strong><\/h5>\n

The authors were responsible for the conception, writing, and revision of the manuscript.<\/p>\n

REFERENCES<\/strong><\/h5>\n
    \n
  1. Vedantam G, Clark A, Chu M, McQuade R, Mallozzi M, Viswanathan VK. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microb. 2012;3(2):121-34. doi:10.4161\/gmic.19399<\/li>\n
  2. Mpakogiannis K, Fousekis FS, Elemes S, Mantellos E, Christaki E, Katsanos KH. Extraintestinal Manifestations of Clostridioides difficile Infections: An Overview. Antibiotics. 2025;14(7):670. doi:10.3390\/antibiotics14070670<\/li>\n
  3. Hafeez B, Aitken T, Cockburn E, Tinson AJ. Extraintestinal Clostridium difficile infection presenting as spontaneous bacterial peritonitis. BMJ Case Rep. 2025;18(2):e262106. doi:10.1136\/bcr-2024-262106<\/li>\n
  4. Jump RL. Clostridium Difficile Infection in Older Adults. Aging health. 2013;9(4):403-14. doi:10.2217\/ahe.13.37<\/li>\n
  5. Libby DB, Bearman G. Bacteremia due to Clostridium difficile\u2014review of the literature. Int J Infect Dis. 2009;13(5):e305-e309. doi:10.1016\/j.ijid.2009.01.014<\/li>\n
  6. Jacobs A, Barnard K, Fishel R, Gradon JD. Extracolonic Manifestations of Clostridium difficile Infections. Medicine (Baltimore). 2001;80(2):88-101. doi:10.1097\/00005792-200103000-00002<\/li>\n
  7. Urb\u00e1n E, Terhes G, Gajd\u00e1cs M. Extraintestinal Clostridioides difficile Infections: Epidemiology in a University Hospital in Hungary and Review of the Literature. Antibiotics (Basel). 2020;9(1):16. doi:10.3390\/antibiotics9010016<\/li>\n
  8. Kazanji N, Gjeorgjievski M, Yadav S, Mertens AN, Lauter C. Monomicrobial vs Polymicrobial Clostridium difficile Bacteremia: A Case Report and Review of the Literature. Am J Med. 2015;128(9):e19-e26. doi:10.1016\/j.amjmed.2015.05.014<\/li>\n
  9. Chatterjee T, Roy M, Ahmad S. Treatment of Extra-Intestinal Clostridioides difficile Abscess following Acute Appendicitis. Eur J Case Rep Intern Med. 2022;9(9):003489. doi:10.12890\/2022_003489<\/li>\n
  10. Garc\u00e1a-Lechuz JM, Hernang\u00f3mez S, Juan RS, Pel\u00e1ez T, Alcal\u00e1 L, Bouza E. Extra-intestinal infections caused by Clostridium difficile. Clin Microbiol Infect. 2001;7(8):453-57. doi:10.1046\/j.1469-0691.2001.00313.x<\/li>\n
  11. Gravisse J, Barnaud G, Hanau-Ber\u00e7ot B, Raskine L, Riahi J, Gaillardet J L, et al. Clostridium difficile brain empyema after prolonged intestinal carriage. J Clin Microbiol. 2003;41(1):509-11. doi:10.1128\/JCM.41.1.509-511.2003<\/li>\n
  12. Hudson DA, Gibb AP, Gill MJ. Empyema Caused by Clostridium difficile. Can J Infect Dis. 1999;10(2):170-1. doi:10.1155\/1999\/968940<\/li>\n
  13. Mohamed A, Sostre V, Patel H, Patel P, Ortiz LC, Baddoura WJ. Clostridium difficile Causing Empyema. Case Rep Gastroenterol. 2018;12(3):633-639. doi:10.1159\/000493184<\/li>\n
  14. Onwubalili JK. Sickle cell disease and infection. J Infect. 1983;7(1):2-20. doi:10.1016\/S0163-4453(83)90863-0<\/li>\n
  15. Pron B, Merckx J, Touzet P, Ferroni A, Poyart C, Berche P, et al. Chronic septic arthritis and osteomyelitis in a prosthetic knee joint due to Clostridium difficile. Eur J Clin Microbiol Infect Dis. 1995;14(7):599-601. doi:10.1007\/BF01690732<\/li>\n
  16. Nyc O, Krutova M, Kriz J, Matejkova J, Bebrova E, Hysperska V, et al. Clostridium difficile ribotype 078 cultured from post-surgical non-healing wound in a patient carrying ribotype 014 in the intestinal tract. Folia Microbiol (Praha). 2015;60(6):541-4. doi:10.1007\/s12223-015-0392-0<\/li>\n
  17. Onada Y, Endo S, Umemoto T, Kajino T, Amasaki Y, Furusaki A. Extraintestinal Clostridium difficile infection due to a ribotype different from that isolated from the feces of the patient: A case report. Anaerobe. 2017;47:185-7. doi:10.1016\/j.anaerobe.2017.05.018<\/li>\n
  18. Hagiya H, Kimura K, Ueda A, Nishi I, Yamamoto N, Yoshida H, et al. Infective thoracic aortic aneurysm caused by Clostridium difficile after endovascular aortic repair. J Infect Chemother. 2017;23(1):62-4. doi:10.1016\/j.jiac.2016.08.002<\/li>\n
  19. Zimmermann O, K\u00f6chel H, Bohne W, Pollok-Kopp B, Passenberg P, Gro\u00df U. A Case Report and Review of the Literature: Reactive Arthritis Caused by Clostridioides difficile ribotype 027. Front Microbiol. 2022;13:837422. doi:10.3389\/fmicb.2022.837422<\/li>\n
  20. Xia Y, Hu HZ, Liu S, Pothoulakis C, Wood JD. Clostridium difficile toxin A excites enteric neurones and suppresses sympathetic neurotransmission in the guinea pig. Gut. 2000;46(4):481-6. doi:10.1136\/gut.46.4.481<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    ACHAIKI IATRIKI | 2026; 45(3):131\u2013134 Editorial Konstantinos C. Mpakogiannis1, Ioanna-Nefeli Mastorogianni1, Fotios S. Fousekis2, Konstantinos H. Katsanos1<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[627],"tags":[],"class_list":["post-2023","post","type-post","status-publish","format-standard","hentry","category-volume-45-2026-issue-3"],"_links":{"self":[{"href":"https:\/\/achaiki-iatriki.gr\/index.php?rest_route=\/wp\/v2\/posts\/2023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/achaiki-iatriki.gr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/achaiki-iatriki.gr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/achaiki-iatriki.gr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/achaiki-iatriki.gr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2023"}],"version-history":[{"count":3,"href":"https:\/\/achaiki-iatriki.gr\/index.php?rest_route=\/wp\/v2\/posts\/2023\/revisions"}],"predecessor-version":[{"id":2058,"href":"https:\/\/achaiki-iatriki.gr\/index.php?rest_route=\/wp\/v2\/posts\/2023\/revisions\/2058"}],"wp:attachment":[{"href":"https:\/\/achaiki-iatriki.gr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/achaiki-iatriki.gr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/achaiki-iatriki.gr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}